National Institute on Aging (NIA)
2,052
317
455
1,328
Key Highlights
Risk & Performance
Pipeline Risk Assessment
Pipeline Risk Assessment
Based on historical performance
Moderate Risk
Score: 35/100
4.8%
98 terminated/withdrawn out of 2052 trials
93.1%
+6.6% vs industry average
7%
137 trials in Phase 3/4
53%
709 of 1328 completed trials have results
Key Signals
Enrollment Performance
Analytics
Activity Timeline
Global Presence
Clinical Trials (2052)
ARTFL LEFFTDS Longitudinal Frontotemporal Lobar Degeneration (ALLFTD)
Role: collaborator
Effects of Urolithin A Supplementation on Glucose Metabolism in Healthy Adults 55 >= Years Old: A Randomized Triple-Masked Controlled Clinical Trial
Role: lead
The Progressive Supranuclear Palsy Clinical Trial Platform
Role: collaborator
Genetic Characterization of Movement Disorders and Dementias
Role: lead
Impact of Extreme Heat on Myocardial Blood Flow and Flow Reserve in Young and Older Adults
Role: collaborator
Using a Wireless Controller to Deliver a Lighting Intervention to Persons With Dementia
Role: collaborator
Deprescribing in Patients Living With Dementia With Caregiver and Provider Nudges
Role: collaborator
Diabetes Prevention Program Outcomes Study
Role: collaborator
Amyloid PET Imaging in the Baltimore Longitudinal Study of Aging
Role: lead
REmote Virtual Inspiration: Vitality and Energy
Role: collaborator
Technology and Family Thriving Study
Role: collaborator
Older Adults, Methadone, and Cognitive Function
Role: collaborator
Utilizing Palliative Leaders In Facilities to Transform Care for Alzheimer's Disease
Role: collaborator
Examining Genetic Factors That Affect the Severity of 22q11.2 Deletion Syndrome
Role: collaborator
Testing the CHAT Program for Patients With Heart Failure
Role: collaborator
Mechanisms Accounting for Unexplained Anemia in the Elderly
Role: lead
Wearable Biofeedback for Swallowing Disorders Rehabilitation in Stroke and Parkinson Disease
Role: collaborator
Longitudinal Early-onset Alzheimer's Disease Study Protocol
Role: collaborator
Palliative Care Integration in Pediatric Oncology Phase 1 Clinical Trials
Role: collaborator
N-of-1 for Beta-Blockers in Cardiac Amyloidosis
Role: collaborator